Chiusura precedente | 218,14 |
Aperto | 222,31 |
Denaro | 219,00 x 1300 |
Lettera | 220,11 x 1100 |
Min-Max giorno | 212,90 - 223,27 |
Intervallo di 52 settimane | 206,60 - 369,69 |
Volume | |
Media Volume | 2.144.603 |
Capitalizzazione | 78,26B |
Beta (5 anni mensile) | 1,17 |
Rapporto PE (ttm) | 47,23 |
EPS (ttm) | 4,64 |
Prossima data utili | 18 apr 2022 - 22 apr 2022 |
Rendimento e dividendo (forward) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 335,53 |
SUNNYVALE, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2022. All prior year per-share information has been retroactively adjusted to reflect a three-for-one stock split. Q1 Highlights Worldwide da Vinci procedures grew approximately 19% compared with the first quarter of 2021. The first quarte
SUNNYVALE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2021. Reported revenue and procedure results are consistent with the Company’s press release issued on January 12, 2022. Q4 Highlights Worldwide da Vinci procedures increased approximately 19% compared with the fourth quarter of 2020, dr
SUNNYVALE, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2021 financial results ahead of its participation at the 40th Annual J.P. Morgan Healthcare Conference occurring January 10-13, 2022. Financial and Operational Highlights Fourth quarter 2021 worldwide da Vinci procedures grew appro